ProQR Therapeutics N.V. (PRQR) Insider Trading
Sector: Biotechnology · Market Cap: $223M · 2 insider purchases in the last 7 days
| INSIDER | DATE | SHARES | PRICE | TOTAL VALUE | OWNED AFTER | Δ OWNED | FILING |
|---|---|---|---|---|---|---|---|
| De Boer Daniel Anton CEO | Jul 9, 2026 | 150,000 | $1.74 | $261K | 300,000 | +100.0% | |
| De Boer Daniel Anton CEO | Jul 7, 2026 | 150,000 | $1.59 | $239K | 150,000 | — |
Want more?
Sign up free to see 30+ days of history, set alerts, and track PRQR on your watchlist.
Start for FreeAbout ProQR Therapeutics N.V. Insider Trading
1 insider at ProQR Therapeutics N.V. (PRQR) has purchased stock in the past 90 days, totaling $500K across 2 transactions (300,000 shares).
The most recent purchase was by CEO de Boer Daniel Anton on July 9, 2026 — a $261K buy of 150,000 shares at $1.74, bringing their total holdings to 300,000 shares.
This insider buying is notable given that PRQR had no recorded open market purchases in the nine months before that.
PRQR is in the Biotechnology sector within the Biotechnology industry with a market cap of $223M.
Track PRQR insider trading activity, set up email alerts, and get AI-powered trade analysis with a free Insider Trading Tracker account.